BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 20566858)

  • 1. Mycobacterium tuberculosis persistence mutants identified by screening in isoniazid-treated mice.
    Dhar N; McKinney JD
    Proc Natl Acad Sci U S A; 2010 Jul; 107(27):12275-80. PubMed ID: 20566858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of interactions of clinical mutants of catalase-peroxidase (KatG) responsible for isoniazid resistance in Mycobacterium tuberculosis with derivatives of isoniazid.
    Unissa AN; Doss C GP; Kumar T; Swathi S; Lakshmi AR; Hanna LE
    J Glob Antimicrob Resist; 2017 Dec; 11():57-67. PubMed ID: 28743650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of Novel Mycobacterium tuberculosis Isoniazid Resistance Mutations Not Detectable by Common Molecular Tests.
    Kandler JL; Mercante AD; Dalton TL; Ezewudo MN; Cowan LS; Burns SP; Metchock B; ; Cegielski P; Posey JE
    Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30082293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of enzymatic activities of new KatG mutants from low- and high-level isoniazid-resistant clinical isolates of Mycobacterium tuberculosis.
    Brossier F; Boudinet M; Jarlier V; Petrella S; Sougakoff W
    Tuberculosis (Edinb); 2016 Sep; 100():15-24. PubMed ID: 27553406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.
    Torres JN; Paul LV; Rodwell TC; Victor TC; Amallraja AM; Elghraoui A; Goodmanson AP; Ramirez-Busby SM; Chawla A; Zadorozhny V; Streicher EM; Sirgel FA; Catanzaro D; Rodrigues C; Gler MT; Crudu V; Catanzaro A; Valafar F
    Emerg Microbes Infect; 2015 Jul; 4(7):e42. PubMed ID: 26251830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA.
    Guo H; Seet Q; Denkin S; Parsons L; Zhang Y
    J Med Microbiol; 2006 Nov; 55(Pt 11):1527-1531. PubMed ID: 17030912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates.
    Islam MM; Tan Y; Hameed HMA; Liu Z; Chhotaray C; Liu Y; Lu Z; Cai X; Tang Y; Gao Y; Surineni G; Li X; Tan S; Guo L; Cai X; Yew WW; Liu J; Zhong N; Zhang T
    Clin Microbiol Infect; 2019 Aug; 25(8):1041.e1-1041.e7. PubMed ID: 30583053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of dfrA and inhA mutations to the detection of isoniazid-resistant Mycobacterium tuberculosis isolates.
    Ho YM; Sun YJ; Wong SY; Lee AS
    Antimicrob Agents Chemother; 2009 Sep; 53(9):4010-2. PubMed ID: 19581462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights on the Mechanism of Action of INH-C
    Vila-Viçosa D; Victor BL; Ramos J; Machado D; Viveiros M; Switala J; Loewen PC; Leitão R; Martins F; Machuqueiro M
    Mol Pharm; 2017 Dec; 14(12):4597-4605. PubMed ID: 29091448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis.
    Unissa AN; Subbian S; Hanna LE; Selvakumar N
    Infect Genet Evol; 2016 Nov; 45():474-492. PubMed ID: 27612406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the GenoType MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens.
    Hillemann D; Rüsch-Gerdes S; Richter E
    J Clin Microbiol; 2007 Aug; 45(8):2635-40. PubMed ID: 17537937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations of mutations in katG, oxyR-ahpC and inhA genes and in vitro susceptibility in Mycobacterium tuberculosis clinical strains segregated by spoligotype families from tuberculosis prevalent countries in South America.
    Dalla Costa ER; Ribeiro MO; Silva MS; Arnold LS; Rostirolla DC; Cafrune PI; Espinoza RC; Palaci M; Telles MA; Ritacco V; Suffys PN; Lopes ML; Campelo CL; Miranda SS; Kremer K; da Silva PE; Fonseca Lde S; Ho JL; Kritski AL; Rossetti ML
    BMC Microbiol; 2009 Feb; 9():39. PubMed ID: 19228426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotypic detection of rifampicin and isoniazid resistant Mycobacterium tuberculosis strains by DNA sequencing: a randomized trial.
    Abdelaal A; El-Ghaffar HA; Zaghloul MH; El Mashad N; Badran E; Fathy A
    Ann Clin Microbiol Antimicrob; 2009 Jan; 8():4. PubMed ID: 19183459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations of rpoB, katG, inhA and ahp genes in rifampicin and isoniazid-resistant Mycobacterium tuberculosis in Kyrgyz Republic.
    Isakova J; Sovkhozova N; Vinnikov D; Goncharova Z; Talaibekova E; Aldasheva N; Aldashev A
    BMC Microbiol; 2018 Mar; 18(1):22. PubMed ID: 29566660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of the synergistic activity of ethambutol and isoniazid against
    Zhu C; Liu Y; Hu L; Yang M; He ZG
    J Biol Chem; 2018 Oct; 293(43):16741-16750. PubMed ID: 30185616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome sequencing of Mycobacterium tuberculosis clinical isolates revealed isoniazid resistance mechanisms undetected by conventional molecular methods.
    Laurent S; Zakham F; Bertelli C; Merz L; Nicod L; Mazza-Stalder J; Greub G; Jaton K; Opota O
    Int J Antimicrob Agents; 2020 Aug; 56(2):106068. PubMed ID: 32603684
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Evaluation of the genotype MTBDR assay for rapid detection of rifampin and isoniazid resistance in clinical Mycobacterium tuberculosis complex clinical isolates].
    Aslan G; Tezcan S; Emekdaş G
    Mikrobiyol Bul; 2009 Apr; 43(2):217-26. PubMed ID: 19621606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of embB codon 306 mutations into clinical Mycobacterium tuberculosis strains alters susceptibility to ethambutol, isoniazid, and rifampin.
    Safi H; Sayers B; Hazbón MH; Alland D
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2027-34. PubMed ID: 18378710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of novel loci associated with mycobacterial isoniazid resistance.
    Viswanathan G; Yadav S; Raghunand TR
    Tuberculosis (Edinb); 2016 Jan; 96():21-6. PubMed ID: 26786650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characteristics of rifampin and isoniazid resistant Mycobacterium tuberculosis strains from Beijing, China.
    Jiao WW; Mokrousov I; Sun GZ; Li M; Liu JW; Narvskaya O; Shen AD
    Chin Med J (Engl); 2007 May; 120(9):814-9. PubMed ID: 17531124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.